Mirnas in systemic sclerosis patients with pulmonary arterial hypertension: markers and effectors

HIGHLIGHTS

  • who: Mor Zaaroor Levy and collaborators from the Autoimmune Research Laboratory, Meir Medical Center, Kfar Saba, Israel have published the Article: MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors, in the Journal: Biomedicines 2022, 10, 629. of 30/Oct/2021
  • what: The aim of this study was to find markers that would allow diagnosis of PAH in the early stages. This study included the entire population of SSc-PAH patients at Meir Medical Center (12 patients) and 25 SSc-noPAH patients, whose blood samples were consecutively collected. Blood samples are collected . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?